Navigation Links
NYU Langone experts present at American College of Rheumatology 2011 Annual Meeting
Date:11/4/2011

Experts from NYU Langone Medical Center will present new research findings and clinical insight into the treatment of rheumatic and bone diseases in a variety of presentations at the American College of Rheumatology (ACR) 2011 Annual Scientific Meeting in Chicago, November 5-9, 2011.

Press Conferences

Osteoarthritis and Bone Unintended Consequences: Increased Prescription of Narcotic Analgesics for OA in the Elderly is Associated with Increased Falls and Fractures in the Post-Vioxx Era
Lydia Rolita, MD and Bruce N. Cronstein, MD
Monday, November 7 at 8:30AM
Following the removal of Vioxx from the market there was a marked increase in the prescription of narcotic analgesics. Subsequently, the number of falls and fractures among the elderly population with osteoarthritis also went up which was attributed to patients prescribed narcotic analgesics. The findings strongly indicate that recommendations for the treatment of chronic pain be re-evaluated.

Lupus, Gout and Vaccines Favorable Prognosis in a Large, Prospective Multicenter Study of Lupus Pregnancies
Jill P. Buyon, MD
Tuesday, November 8 at 8:30AM
A study of pregnant women with systemic lupus erythematosus found eighty percent (80%) of women had positive outcomes, with adverse outcomes associated with an increase in lupus activity during pregnancy, high titer aPL antibody, and higher levels of uric acid at baseline. This large, prospective study provides reassurances to those patients with stable lupus considering pregnancy and suggests guidelines for those at-risk patients.

Presentations, Demonstrations & Panel Discussion

A Distinctive Oral Microbiome Characterizes Periodontitis in Patients with Early Rheumatoid Arthritis
Jose U. Scher, MD
Tuesday, November 8 at 4:45PM
This presentation investigates the abundance of a unique subgingival oral microbiota in patients with new-onset, never-treated rheumatoid arthritis, compared to those with chronic-established RA and healthy individuals. The study suggests that further identification and characterization of Porphyromonas species as well as other bacteria may help explain the reported link between RA and periodontal disease.

Successes in Rheumatology Comparative Effectiveness Research Registries/Cohorts That Have Made a Difference in Rheumatology
Jeffrey Greenberg, MPH, MD
Saturday, November 5 at 3:00PM
This presentation highlights the value of comparative effectiveness research and how it enables the evaluation and comparison of the health outcomes, risks and benefits of established, commonly used treatments without the expense and limitations of randomized, controlled clinical trials.

ACR State of the Art Lecture Biomarkers in Systemic Lupus Erythematosus: Where Do We Stand?
Jill P. Buyon, MD and Anca D. Askanase, MD
Monday November 7 at 1:00PM
This lecture will provide an understanding of the ongoing efforts to identify and validate biomarkers needed to advance the diagnosis, monitoring and treatment of systemic lupus erythematosus.

Rheumatic Disease Update Paraneoplastic Rheumatic Disorders
Yusef Yazici, MD
Monday, November 7 at 2:30PM
The presentation will look at rheumatologic disorders known to be associated with a variety of malignancies and the challenge clinicians' face in identifying a malignancy that may not be apparent when rheumatic disease first appears.

Leveraging Existing Resources for Your Research Introduction to the Clinical and Translational Science Award
Bruce N. Cronstein, MD
Monday, November 7 at 4:30PM
This session will introduce early career investigators to CTSA research resources and alternatives when a CTSA center is not available.

ACR Clinical Symposia Hyperuricemia and Gout: Mechanisms and Morbidity
Michael H. Pillinger, MD
Tuesday, November 8 at 1:00PM
This discussion offers clinicians an update on recent findings on the pathogenesis and consequences of hyperuricemia and gout, one of the most common forms of inflammatory arthritis in men over the age of 50.

ACR Workshops - Patient Questionnaires to Monitor Status and Document Improvement in Standard Care: Practical Considerations
Theodore Pincus, MD
Tuesday, November 8 at 4:00PM
During this workshop, attendees will learn about the significance of patient questionnaire data in the prognosis of long-term care, how a rheumatology practice can use patient questionnaires to monitor and document patient status, identify incomplete responses to therapies or a need for changes in tight control of inflammation.


'/>"/>

Contact: Craig Andrews
craig.andrews@nyumc.org
212-404-3511
NYU Langone Medical Center / New York University School of Medicine
Source:Eurekalert

Related biology news :

1. Researchers at NYU Langone Medical Center review the microbiome and its possible role in cancers
2. NYU Langone researchers reveal a new mechanism of genomic instability
3. NYU Langone experts find MRI techniques can detect early osteoarthritis
4. NYU Langone researchers identify a signaling pathway as possible target for cancer treatment
5. NYU Langone Medical Centers tip sheet to the 2011 Alzheimers Association International Conference
6. NYU Langone experts present advances at American Association of Neurological Surgeons Meeting
7. NYU Langone Medical Center receives $5.4 million NYSTEM grant for stem cell research
8. NYU Langone Medical Center awarded NIH grants totaling $1,560,000
9. NYU Langone Medical Center researchers find micro RNA plays a key role in melanoma metastasis
10. Specialized courts for environment cases among proposals as law experts mull green governance
11. MU Industrial Assessment Center saves companies thousands, trains future energy efficiency experts
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... FRANCISCO and BANGALORE, India , ... of EdgeVerve Systems, a product subsidiary of Infosys (NYSE: ... provider, today announced a global partnership that will ... way to use mobile banking and payment services. ... is a key innovation area for financial services, but it ...
(Date:4/15/2016)... April 15, 2016  A new partnership announced ... accurate underwriting decisions in a fraction of the ... priced and high-value life insurance policies to consumers ... With Force Diagnostics, rapid testing (A1C, Cotinine ... readings (blood pressure, weight, pulse, BMI, and activity ...
(Date:3/31/2016)... 2016  Genomics firm Nabsys has completed a financial ... Bready , M.D., who returned to the company in ... leadership team, including Chief Technology Officer, John Oliver ... Nurnberg and Vice President of Software and Informatics, ... Dr. Bready served as CEO of Nabsys from ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
(Date:6/23/2016)... , June 23, 2016  The Prostate Cancer Foundation (PCF) ... precise treatments and faster cures for prostate cancer. Members of the Class of ... 15 countries. Read More About the Class of 2016 ... ... ...
(Date:6/23/2016)... ... , ... STACS DNA Inc., the sample tracking software company, today announced that ... joined STACS DNA as a Field Application Specialist. , “I am thrilled that ... of STACS DNA. “In further expanding our capacity as a scientific integrator, Hays brings ...
(Date:6/23/2016)... LONDON , June 23, 2016 ... & Hematology Review, 2016;12(1):22-8 http://doi.org/10.17925/OHR.2016.12.01.22 ... Review , the peer-reviewed journal from touchONCOLOGY, ... the escalating cost of cancer care is placing ... a result of expensive biologic therapies. With the ...
Breaking Biology Technology: